Sexually Transmitted Infections (Excluding HIV)

Manson's Tropical Diseases, Twenty-second Edition

Volumn , Issue , 2008, Pages 403-434

  Richens, John ^a   Mabey, David C W ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85159007678     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4470-3.50025-2     Document Type: Chapter

References (93)

1. KK Holmes, PA Mårdh, PF Sparling, et al. (2007) Sexually Transmitted Diseases 4th edn. New York: McGraw-Hill
2. KF Schulz, W Cates Jr and PR O'Mara (1987) Pregnancy loss, infant death, and suffering: legacy of syphilis and gonorrhoea in Africa. Genitourin Med 63 320-325.
3. MMWR (2006) 2006 Guidelines for Treatment of Sexually Transmitted Diseases Treatment. Morbidity and Mortality Weekly Report 55(RR11), 1-94.
4. G Dallabetta, M Laga and P Lamptey (2006) Control and Prevention of Sexually Transmitted Diseases: A Handbook for Design and Management of Programs Arlington: AIDSCAP/Family Health International
5. JA Rottingen, DW Cameron and GP Garnett (2001) A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV - How much really is known? Sex Transm Dis 28(10), 579-597.
6. S Mullick, D Watson-Jones, M Beksinska, et al. (2005) Sexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries. Sex Transm Infect 81(4), 294-302.
7. MJ Wawer, NK Sewankambo, D Serwadda, et al. (1999) Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Lancet 353(9152), 525-535.
8. DG Muir and MA Belsey (1980) Pelvic inflammatory disease and its consequences in the developing world. Am J Obstet Gynecol 138(7), 913-928.
9. U Larsen (2000) Primary and secondary infertility in sub-Saharan Africa. Int J Epidemiol 29(2), 285-291.
10. SK Hira, GJ Bhat, JB Patel, et al. (1985) Early congenital-syphilis - clinico-radiologic features in 202 patients. Sex Transm Dis 12(4), 177-183.
11. D Watson-Jones, J Changalucha, B Gumodoka, et al. (2002) Syphilis in pregnancy in Tanzania. I. Impact of maternal syphilis on outcome of pregnancy. J Infect Dis 186(7), 940-947.
12. KM Blankenship, SR Friedman, S Dworkin, et al. (2006) Structural interventions: Concepts, challenges and opportunities for research. J Ur Health-Bull NY Acad Med 83(1), 59-72.
13. RJ Hayes, KF Schulz and FA Plummer (1995) The cofactor effect of genital ulcers on the per-exposure risk of HIV transmission in sub-Saharan Africa. J Trop Med Hyg 98(1), 1-8.
14. MS Cohen, IF Hoffman, RA Royce, et al. (1997) Reduction of concentration of HIV-1, in semen after treatment of urethritis: Implications for prevention of sexual transmission of HIV-1. Lancet 349(9069), 1868-1873.
15. H Grosskurth, F Mosha, J Todd, et al. (1995) Impact of improved treatment of sexually-transmitted diseases on HIV-infection in rural Tanzania - randomized controlled trial. Lancet 346(8974), 530-536.
16. P French (6 Feb 2007) Consultations requiring sexual history taking. British Association for Sexual Health and HIV 2006 National Guidelines 2007. Online. Available: http://www.bashh.org/guidelines/2007/sexual_history_taking_0107.pdf
17. Guidelines for the Management of Sexually Transmitted Infections World Health Organization 2003. Online. Available: http://www.emro.who.int/aiecf/web79.pdf
18. P Mayaud and DCW Mabey (2000) Managing sexually transmitted diseases in the tropics: is a laboratory really needed? Trop Doc 30(1), 42-46.
19. J Pepin, F Sobela, S Deslandes, et al. (2001) Etiology of urethral discharge in West Africa: the role of Mycoplasma genitalium and Trichomonas vaginalis. Bull WHO 79(2), 118-126.
20. A Wikstrom and JS Jensen (2006) Mycoplasma genitalium: a common cause of persistent urethritis among men treated with doxycycline. Sex Transm Infect 82(4), 276-279.
21. P Morency, MJ Dubois, G Gresenguet, et al. (2001) Aetiology of urethral discharge in Bangui, Central African Republic. Sex Transm Infect 77(2), 125-129.
22. JDC Ross and JS Jensen (2006) Mycoplasma genitalium as a sexually transmitted infection: implications for screening, testing, and treatment. Sex Transm Infect 82(4), 269-271.
23. CS Bradshaw, SN Tabrizi, TRH Read, et al. (2006) Etiologies of nongonococcal urethritis: Bacteria, viruses, and the association with orogenital exposure. J Infect Dis 193(3), 336-345.
24. H Grosskurth, P Mayaud, F Mosha, et al. (1996) Asymptomatic gonorrhoea and chlamydial infection in rural Tanzanian men. Br Med J 312(7026), 277-280.
25. PS Pelouze (1941) Gonorrhoea in the Male and Female Philadelphia: WB Saunders
26. PC Bewes (1986) Urethroplasty for Stricture. Trop Doc 16(3), 121-128.
27. DN Osegbe and EO Amaku (1981) Gonococcal Strictures in Young-Patients. Urology 18(1), 37-41.
28. M Collet, J Reniers, E Frost, et al. (1988) Infertility in Central-Africa - Infection is the cause. Int J Gynecol Obstet 26(3), 423-428.
29. B Elliott, RC Brunham, M Laga, et al. (1990) Maternal gonococcal infection as a preventable risk factor for low-birth-weight. J Infect Dis 161(3), 531-536.
30. FA Plummer, M Laga, RC Brunham, et al. (1987) Postpartum upper genital-tract infections in Nairobi, Kenya - epidemiology, etiology and risk-factors. J Infect Dis 156(1), 92-98.
31. CM Stein and MG Hanly (1987) Acute tropical polyarthritis in Zimbabwe - a prospective search for a gonococcal etiology. Annals Rheum Dis 46(12), 912-914.
32. P Kestelyn, J Bogaerts and A Meheus (1987) Gonorrheal keratoconjunctivitis in African Adults. Sex Transm Dis 14(4), 191-194.
33. M Laga, FA Plummer, P Piot, et al. (1988) Prophylaxis of gonococcal and chlamydial ophthalmia neonatorum - a comparison of silver-nitrate and tetracycline. N Engl J Med 318(11), 653-657.
34. CA Ison, JR Dillon and JW Tapsall (1998) The epidemiology of global antibiotic resistance among Neisseria gonorrhoeae and Haemophilus ducreyi. Lancet 351 8-11.
35. SJ Isenberg, L Apt and M Wood (1995) A controlled trial of povidone-iodine as prophylaxis against ophthalmia neonatorum. N Engl J Med 332(9), 562-566.
36. C Bignell, CA Ison and E Jungmann (2006) Testing guidelines for gonorrhoea. Sex Transm Infect 82(suppl 4), iv6-iv9.
37. SB Lyss, ML Kamb, TA Peterman, et al. (2003) Chlamydia trachomatis among patients infected with and treated for Neisseria gonorrhoeae in sexually transmitted disease clinics in the United States. Annals Intern Med 139(3), 178-185.
38. GP Garnett and FJ Bowden (2000) Epidemiology and control of curable sexually transmitted diseases - Opportunities and problems. Sex Transm Dis 27(10), 588-599.
39. SP Wang and JT Grayston (1974) Human Serology in Chlamydia-Trachomatis Infection with Microimmunofluorescence. J Infect Dis 130(4), 388-397.
40. RW Peeling, J Kimani, F Plummer, et al. (1997) Antibody to Chlamydial hsp60 predicts an increased risk for chlamydial pelvic inflammatory disease. J Infect Dis 175(5), 1153-1158.
41. L Westrom and PA Mardh (1983) Chlamydial salpingitis. Br Med Bull 39(2), 145-150.
42. MO Beem and EM Saxon (1977) Respiratory-tract colonization and a distinctive pneumonia syndrome in infants infected with chlamydia-trachomatis. N Engl J Med 296(6), 306-310.
43. EJ Watson, A Templeton, I Russell, et al. (2002) The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systematic review. J Med Microbiol 51(12), 1021-1031.
44. CY Lau and AK Qureshi (2002) Azithromycin versus doxycycline for genital chlamydial infections - A meta-analysis of randomized clinical trials. Sex Transm Dis 29(9), 497-502.
45. D Watson-Jones, K Mugeye, P Mayaud, et al. (2000) High prevalence of trichomoniasis in rural men in Mwanza, Tanzania: results from a population based study. Sex Transm Infect 76(5), 355-362.
46. P Wolnerhanssen, JN Krieger, CE Stevens, et al. (1989) Clinical manifestations of vaginal trichomoniasis. JAMA 261(4), 571-576.
47. SL Hillier, RP Nugent, DA Eschenbach, et al. (1995) Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. N Engl J Med 333(26), 1737-1742.
48. RP Nugent, MA Krohn and SL Hillier (1991) Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol 29(2), 297-301.
49. CA Ison and PE Hay (2002) Validation of a simplified grading of Gram stained vaginal smears for use in genitourinary medicine clinics. Sex Transm Infect 78(6), 413-415.
50. GW Hammond, M Slutchuk, J Scatliff, et al. (1980) Epidemiologic, clinical, laboratory, and therapeutic features of an urban outbreak of chancroid in North-America. Rev Infect Dis 2(6), 867-879.
51. SA Morse (1989) Chancroid and Hemophilus-Ducreyi. Clin Microbiol Rev 2(2), 137-157.
52. N O'Farrell (1999) Increasing prevalence of genital herpes in developing countries: implications for heterosexual HIV transmission and STI control programmes. Sex Transm Infect 75(6), 377-384.
53. FA Plummer, H Nsanze, P Karasira, et al. (1983) Epidemiology of Chancroid and Hemophilus Ducreyi in Nairobi, Kenya. Lancet 2(8362), 1293-1295.
54. G Hart (1975) Sexual behavior in a war environment. J Sex Res 11(3), 218-226.
55. DW Cameron, LJ Dcosta, GM Maitha, et al. (1989) Female to male transmission of human immunodeficiency virus Type-1 - risk-factors for seroconversion in men. Lancet 2(8660), 403-407.
56. FA Plummer, JN Simonsen, DW Cameron, et al. (1991) Cofactors in male-female sexual transmission of human-immunodeficiency-virus type-1. J Infect Dis 163(2), 233-239.
57. R Steen (2001) Eradicating chancroid. Bull WHO 79(9), 818-826.
58. JA Al Tawfiq, AC Thornton, BP Katz, et al. (1998) Standardization of the experimental model of Haemophilus ducreyi infection in human subjects. J Infect Dis 178(6), 1684-1687.
59. JA Al Tawfiq, KR Fortney, BP Katz, et al. (2000) An isogenic hemoglobin receptor-deficient mutant of Haemophilus ducreyi is attenuated in the human model of experimental infection. J Infect Dis 181(3), 1049-1054.
60. MK Stevens, JL Latimer, SR Lumbley, et al. (1999) Characterization of a Haemophilus ducreyi mutant deficient in expression of cytolethal distending toxin. Infect Immun 67(8), 3900-3908.
61. MV Fast, LJ Dcosta, H Nsanze, et al. (1984) The clinical-diagnosis of genital ulcer disease in men in the tropics. Sex Transm Dis 11(2), 72-76.
62. EH Hudson (1958) Non-venereal syphilis Baltimore: Williams and Wilkins
63. K Wicher, V Wicher, F Abbruscato, et al. (2000) Treponema pallidum subsp pertenue displays pathogenic properties different from those of T-pallidum subsp pallidum. Infect Immun 68(6), 3219-3225.
64. RE Lafond, BJ Molini, WC Van Voorhis, et al. (2006) Antigenic variation of TprK V regions abrogates specific antibody binding in syphilis. Infect Immun 74(11), 6244-6251.
65. T Gjestland (1955) The Oslo study of untreated syphilis. Acta Derm Venereol Suppl 35 1.
66. NR Ingraham (1951) The value of penicillin alone in the prevention and treatment of congenital syphilis. Acta Derm Venereol 31(suppl 24), 60.
67. H Young (2000) Guidelines for serological testing for syphilis. Sex Transm Infect 76(5), 403-405.
68. R Castro, ES Prieto, I Santo, et al. (2003) Evaluation of an enzyme immunoassay technique for detection of antibodies against Treponema pallidum. J Clin Microbiol 41(1), 250-253.
69. RT Rolfs, R Joesoef, EF Hendershot, et al. (1997) A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 337(5), 307-314.
70. G Riedner, M Rusizoka, J Todd, et al. (2005) Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med 353(12), 1236-1244.
71. KK Holmes (2006) Azithromycin versus penicillin for early syphilis - Reply. N Engl J Med 354(2), 205.
72. D Watson-Jones, M Oliff, F Terris-Prestholt, et al. (2005) Antenatal syphilis screening in sub-Saharan Africa: lessons learned from Tanzania. Trop Med Int Health 10(9), 934-943.
73. AK Van der Bij, J Spaargaren, SA Morre, et al. (2006) Diagnostic and clinical implications of anorectal lymphogranuloma venereum in men who have sex with men: A retrospective case-control study. Clin Infect Dis 42(2), 186-194.
74. RF Nieuwenhuis, JM Ossewaarde, HM Gotz, et al. (2004) Resurgence of lymphogranuloma venereum in western Europe: An outbreak of Chlamydia trachomatis serovar L-2 proctitis in The Netherlands among men who have sex with men. Clin Infect Dis 39(7), 996-1003.
75. BS Sengupta (1981) Vulval cancer following or co-existing with chronic granulomatous diseases of vulva - an analysis of its natural-history, clinical manifestation and treatment. Trop Doc 11(3), 110-114.
76. JP Trama, JA Zimmerman, E Mordechai, et al. (2006) Detection of the Chlamydia trachomatis L serovars that cause lymphogranuloma venereum by real-time PC R. J Molec Diagnostics 8(5), 643.
77. A Herring and J Richens (2006) Testing guidelines for Lymphogranuloma venereum. Sex Transm Infect 82(suppl 4), iv23-iv25.
78. N Ofarrell, AA Hoosen, KD Coetzee, et al. (1991) Genital Ulcer Disease in Men in Durban, South-Africa. Genitourinary Med 67(4), 327-330.
79. JS Carter, FJ Bowden, I Bastian, et al. (1999) Phylogenetic evidence for reclassification of Calymmatobacterium granulomatis as Klebsiella granulomatis comb. nov. Int J Systemat Bacteriol 49 1695-1700.
80. ABM Kharsany, AA Hoosen, P Kiepiela, et al. (1997) Growth and cultural characteristics of Calymmatobacterium granulomatis - The aetiological agent of granuloma inguinale (Donovanosis). J Med Microbiol 46(7), 579-585.
81. J Richens (1991) The diagnosis and treatment of Donovanosis (Granuloma Inguinale). Genitourinary Med 67(6), 441-452.
82. J Verdich (1984) Hemophilus-Ducreyi infection resembling Granuloma Inguinale. Acta Dermato-Venereologica 64(5), 452-455.
83. F Bowden (2003) Donovanosis. S Morse, KK Holmes (Eds) Atlas of Sexually Transmitted Infections London: Mosby-Elsevier
84. FJ Bowden, J Mein, C Plunkett, et al. (1996) Pilot study of azithromycin in the treatment of genital donovanosis. Genitourinary Med 72(1), 17-19.
85. MDM Rodriguez, A Obasi, F Mosha, et al. (2002) Herpes simplex virus type 2 infection increases HIV incidence: a prospective study in rural Tanzania. AIDS 16(3), 451-462.
86. WC Reeves, L Corey, HG Adams, et al. (1981) Risk of recurrence after 1st episodes of genital herpes - relation to Hsv type and antibody-response. N Engl J Med 305(6), 315-319.
87. A Wald, J Zeh, G Barnum, et al. (1996) Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Annals Internal Med 124(1), 8-15.
88. N Nagot, A Ouedraogo, V Foulongne, et al. (2007) Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med 356(8), 16-25.
89. RF Rando (1988) Human papillomavirus - implications for clinical medicine. Annals Internal Med 108(4), 628-630.
90. ME Sherman, AT Lorincz, DR Scott, et al. (2003) Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: A 10-year cohort analysis. J Nat Canc Inst 95(1), 46-52.
91. R Maw (2004) Critical appraisal of commonly used treatment for genital warts. Int J Std Aids 15(6), 357-364.
92. LA Koutsky, KA Ault, CM Wheeler, et al. (2002) A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 347(21), 1645-1651.
93. MA Kane, J Sherris, P Coursaget, et al. (2006) HPV vaccine use in the developing world. Vaccine 24 132-139.